Merck Tam sim no nyob rau hauv kev sib tham Advanced mus yuav Cancer Biotech Seagen rau $ 40 nphom

Ntawv loj

Merck & Co

 yog nyob rau hauv advanced tham mus yuav

Seagen

nyob rau hauv ib qho kev pom zoo uas tuaj yeem muaj nuj nqis rau kev kho mob qog noj ntshav ntawm $ 40 nphom lossis ntau dua, raws li tsab ntawv ceeb toom hnub Wednesday.

Ob lub tuam txhab tab tom tham txog tus nqi rau Seagen (ticker: SGEN) saum toj no $ 200-ib-sib koom, The Wall Street Journal tau tshaj tawm hais txog cov neeg paub txog qhov teeb meem, thiab tab tom nrhiav kev pom zoo los yog ua ntej ntawm Merck cov nyiaj tau los peb lub hlis twg thaum Lub Xya Hli 28. Nws tau hais tias tsis muaj kev lav phib xaub tias ob tog yuav mus txog qhov kev pom zoo.

Seagen cov Tshuag tau nce 4.6% rau $ 183.10 hauv kev lag luam ua ntej hnub Thursday. Shares hauv Merck (MRK), uas muaj kev lag luam tus nqi ntau dua $ 234 billion, poob qis.

Tshaj tawm tias ob lub tuam txhab tau pib sib tham tshwm sim lub hli tas los.

Sau rau Lina Saigol ntawm [email tiv thaiv]